4 results
Primary ObjectiveThe primary objective is to show that fusion with the Valeo OL spacer produces similar improvement in MRDQ at all follow-up time points as compared to the same procedure with PEEK cages.Secondary ObjectivesTo show that the fusion…
To provide UT-15C for eligible subjects who participated in study protocol TDE-PH-310
To assess the effect of oral UT-15C with PAH-approved oral monotherapy compared to placebo with PAHapproved oral monotherapy on time to first clinical worsening event (adjudicated), as defined by at least one of the events listed below:- Death (all…
Primary objective: - To investigate the effect of additional levamisole in comparison with placebo from 4 weeks to 6 months after the start of the first episode of steroid-sensitive INS in children (age 2 - 16 years) on the occurrence of relapses…